Codes ATC:
J01DD04
EMLc
Indication
Bacterial meningitis
Code ICD11:
8E71.0Z
INN
Ceftriaxone
Type de médicament
Chemical agent
Groupes d'antibiotiques
Type de liste
Liste de base
(EML)
(EMLc)
(EMLc)
Additional notes
Do not administer with calcium and avoid in infants with hyperbilirubinaemia.
Formulations
Parenteral > General injections > unspecified:
250 mg in vial powder for injection (as sodium salt) ;
1 g in vial powder for injection (as sodium salt) ;
2 g in vial powder for injection (as sodium salt) (EML)
;
500 mg in vial powder for injection (as sodium salt)
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Limite d'âge
> 41 weeks corrected gestational age
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Wikipédia
DrugBank
Recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the addition of new strength formulations of cefotaxime (powder for injection: 500 mg; 1 g; 2 g (as sodium) in vial) to the EML and EMLc.
- the addition of a new strength formulation of ceftriaxone (powder for injection: 500 mg (as sodium) in vial) to the EML and EMLc.
- the addition of new formulations of amoxicillin (dispersible, scored tablet, 250 mg and 500 mg) to the EMLc.
- the deletion of oral formulations of chloramphenicol (capsule 250 mg and oral liquid 150 mg/5 mL (as palmitate)) from the EML and EMLc.
Recommandations de la LME : Bacterial meningitis
Premier choix
Second choix
Premier choix
Second choix